Skip to main content
SpringerLink
Log in

Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?

  • Practice Point
  • Published:

From Nature Clinical Practice Urology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tannock IF et al. (1996) Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 14: 1756–1764

    Article  CAS  Google Scholar 

  2. Kantoff PW et al. (1999) Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of cancer and leukemia group B 9182 study. J Clin Oncol 17: 2506–2513

    Article  CAS  Google Scholar 

  3. Petrylak DP et al. (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351: 1513–1520

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Suzanne Farley, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Chief of Medical Oncology at the San Camillo and Forlanini Hospitals, Rome, Italy

    Cora N Sternberg

Authors
  1. Cora N Sternberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cora N Sternberg.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sternberg, C. Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?. Nat Rev Urol 2, 20–21 (2005). https://doi.org/10.1038/ncpuro0066

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0066

  • Springer Nature Limited

Search

Navigation